Clinical Trials
4
Active:0
Completed:4
Trial Phases
3 Phases
Phase 1:1
Phase 4:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (50.0%)Not Applicable
1 (25.0%)Phase 1
1 (25.0%)Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
Phase 4
Completed
- Conditions
- DyslipidemiaHyperlipidemiaHyperglycemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2012-01-06
- Lead Sponsor
- Radiant Research
- Target Recruit Count
- 140
- Registration Number
- NCT01239004
- Locations
- 🇺🇸
Radiant Research, Chicago, Illinois, United States
The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: PomWonderful JuiceDrug: Placebo juice
- First Posted Date
- 2008-08-05
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Radiant Research
- Target Recruit Count
- 384
- Registration Number
- NCT00728299
Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2011-04-18
- Lead Sponsor
- Radiant Research
- Target Recruit Count
- 31
- Registration Number
- NCT00701727
- Locations
- 🇺🇸
Radiant Research, Chicago, Illinois, United States
ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2011-04-20
- Lead Sponsor
- Radiant Research
- Target Recruit Count
- 25
- Registration Number
- NCT00673881
- Locations
- 🇺🇸
Radiant Research, 515 N State St, #2700, Chicago, Illinois, United States
News
No news found